Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,202.00    54.00 (2.51%)
Bid:
2,200.00
Ask:
2,206.00
Spread: 6.00 (0.273%)
Market Cap: £1.46b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

8 Dec 2017 16:41

RNS Number : 8772Y
Genus PLC
08 December 2017
 

8 December 2017

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional shares on 20 November 2017 under the Genus 2014 Performance Share Plan ('PSP') as listed in table A below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 22 November 2017 on the London Stock Exchange to partly offset income tax and social security liabilities due on the exercise. This exercise and sale was inadvertently not included in the announcement made on 23 November 2017.

 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of conditional shares exercised and ordinary shares sold on 22 November 2017.

 

For further information please contact:

 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

2.

Reason for the notification

a.

Position/status

Group Human Resources Director

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 829 conditional shares under the PSP.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

829

 

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

0p

829

e.

Date of the transaction

2017-11-22

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of 829 shares arising from the exercise of conditional shares under the PSP partly to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,185.42p

829

d.

Aggregated information

· Aggregated volume

· Price

 

 

Aggregated price(s)

 

Total volume(s)

2,185.42p

829

e.

Date of the transaction

2017-11-22

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUWONRBKAURAA
Date   Source Headline
2nd Apr 200812:00 pmRNSMerger Update
1st Apr 20085:33 pmRNSDirector/PDMR Shareholding
31st Mar 20084:00 pmRNSTotal Voting Rights
31st Mar 20084:00 pmRNSBlocklisting Interim Review
20th Mar 20082:08 pmRNSHolding(s) in Company
17th Mar 20083:21 pmRNSHolding(s) in Company
13th Mar 20082:00 pmRNSHolding(s) in Company
29th Feb 20082:00 pmRNSTotal Voting Rights
27th Feb 20085:02 pmRNSDirector/PDMR Shareholding
26th Feb 20084:54 pmRNSDirector/PDMR Shareholding
26th Feb 20087:00 amRNSInterim Results
22nd Feb 200811:56 amRNSHolding(s) in Company
31st Jan 20082:00 pmRNSBlocklisting Interim Review
17th Jan 20087:00 amRNSBoard Changes
15th Jan 20088:00 amRNS1st dealings on AIM
15th Jan 20088:00 amRNSDisposal
14th Jan 20085:40 pmRNSHolding(s) in Company
9th Jan 200811:00 amRNSAppointment of New Adviser
2nd Jan 20083:15 pmRNSTotal Voting Rights
30th Nov 20078:00 amRNSTotal Voting Rights
27th Nov 20077:01 amRNSDisposal
15th Nov 20073:39 pmRNSResult of AGM
15th Nov 20077:01 amRNSAGM Statement
12th Nov 20078:24 amRNSAdmission to Official List
12th Nov 20078:00 amRNSCancellation - 12/11/2007
7th Nov 20077:57 amRNSPublication of Prospectus
6th Nov 200712:51 pmRNSHolding(s) in Company
6th Nov 20077:00 amRNSDisposal
1st Nov 20075:53 pmRNSDirector/PDMR Shareholding
1st Nov 20077:02 amRNSPlacing
31st Oct 20079:20 amRNSTotal Voting Rights
18th Oct 20072:30 pmRNSDirector/PDMR Shareholding
12th Oct 20077:01 amRNSMove to the Official List
4th Oct 20077:01 amRNSDisposal of SyAqua Mexico
28th Sep 20077:01 amRNSTotal Voting Rights
24th Sep 20072:11 pmRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSPreliminary Results
12th Sep 20072:55 pmRNSStatement re: Foot & Mouth
5th Sep 20075:16 pmRNSBlocklisting Interim Review
17th Aug 20072:55 pmRNSChange of Adviser
10th Aug 20074:28 pmRNSAIM Rule 26
6th Aug 20077:01 amRNSStatement Re: Foot & Mouth
25th Jul 20072:00 pmRNSBlocklisting Interim Review
18th Jul 20077:01 amRNSPre-Close Trading Update
7th Jun 20076:35 pmRNSHolding(s) in Company
7th Jun 20076:33 pmRNSHolding(s) in Company
19th Apr 20075:13 pmRNSDirector/PDMR Shareholding
12th Apr 200710:58 amRNSHolding(s) in Company
29th Mar 20077:00 amRNSHolding(s) in Company
13th Mar 20077:02 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.